covid 19 News and Research

RSS

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

A new study aimed to identify COVID-19 vaccination coverage, examine the factors responsible for COVID-19 vaccination coverage and vaccine hesitancy, study adverse events following immunization patterns after COVID-19 vaccination and determine the prevalence of breakthrough infection after COVID-19 vaccination.

30 Nov 2021

Improving access to health care is key to reducing HIV incidence

Many patients living with HIV in rural Africa are not receiving regular treatment, despite recent efforts to increase access to health care across the continent.

30 Nov 2021

Human LRRC15 protein is an inhibitory receptor for SARS-CoV-2 spike-mediated entry

In a recent study, published on the bioRxiv* preprint server, researchers identified human LRRC15 as an inhibitory receptor for SARS-CoV-2 entry, which directly binds to the receptor-binding domain (RBD) of the spike protein with a moderate affinity and inhibits spike-mediated entry.

29 Nov 2021

SARS-CoV-2 Delta spike increases viral virulence and inflammatory cytokine production

In a new study published on the bioRxiv* preprint server, scientists investigated several virological features of the Delta spike protein.

29 Nov 2021

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

In a new study, published on the bioRxiv* preprint server, scientists aimed to determine the reaction of the molnupiravir parent drug (NHC) to different SARS-CoV-2 Variants of Concern (VoCs). They also sought to establish the therapeutic window in a human lung cell model.

29 Nov 2021

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.

29 Nov 2021

Targeted measures to prevent the spread of Omicron variant take effect from 30 November 2021

Targeted measures to prevent the spread of the new COVID-19 Omicron variant take effect from 4am today [Tuesday 30 November].

29 Nov 2021

Cytomegalovirus herpesvirus can accelerate the decline of the immune system, study finds

A research team at the University of Córdoba is studying the alterations that occur in the immune system's T lymphocytes with respect to age and in relation to the cytomegalovirus herpesvirus.

29 Nov 2021

Money recovered in corruption case used for providing life-saving support to vulnerable people in Chad

More than 150,000 people in Chad have been helped with lifesaving UK aid, including emergency food supplies, funded by £4.4 million recovered in a corruption case by the Serious Fraud Office.

29 Nov 2021

Childhood cancer diagnosis not delayed in Canada during the pandemic, study says

During the first 9 months of the COVID-19 pandemic, researchers did not find a significant difference in the number of new cancer diagnoses in Canadian children compared with before the pandemic, according to a study published in CMAJ.

29 Nov 2021

Novel influenza vaccine candidate shows promise

Researchers investigate the potential value of a new vaccine candidate for the influenza virus.

29 Nov 2021

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Researchers attempt to predict future transmission rates by identifying multiple scenarios that could occur over the next year.

29 Nov 2021

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

Researchers study human single nucleotide variants (SNVs) using machine learning to identify amino acid changes that alter kinase-bound sequence motifs.

29 Nov 2021

An update of what is currently known about Omicron

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE).

29 Nov 2021

The Rockefeller Foundation and WHO review strategic directions of collaboration to promote global health

On 8-10 November 2021, Dr Naveen Rao, Senior Vice President, Health and other senior representatives from The Rockefeller Foundation joined World Health Organization representatives to review the strategic directions of collaboration between the two Organizations.

29 Nov 2021

European study endorses dashboards for public reporting during the COVID-19 pandemic

Researchers explore the development of COVID-19 dashboards during the first year of the pandemic.

29 Nov 2021

AVAT, Africa CDC and COVAX release statement regarding donations of COVID-19 vaccines to Africa

Building on lessons learned from our collective experience with dose donations over the past several months, the African Vaccine Acquisition Trust, the Africa Centres for Disease Control and Prevention and COVAX wish to draw the attention of the international community to the situation of donations of COVID-19 vaccines to Africa, and other COVAX participating economies, particularly those supported by the Gavi COVAX Advance Market Commitment.

29 Nov 2021

Simple change can maximize a single cell's production of extracellular vesicles

A simple change in the way donor cells are processed can maximize a single cell's production of extracellular vesicles, which are small nanoparticles naturally secreted by cells, according to new research from researchers at the University of Illinois Chicago.

29 Nov 2021

SARS-CoV-2 can directly invade human kidney cells, research shows

Up to 25% of patients' COVID-19 cases involve acute kidney injury—the kidneys' equivalent of a heart attack.

29 Nov 2021

CDC strengthens recommendation on COVID-19 booster doses

Today, CDC is strengthening its recommendation on booster doses for individuals who are 18 years and older. Everyone ages 18 and older should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.

29 Nov 2021

covid 19 News and Research

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

Improving access to health care is key to reducing HIV incidence

Human LRRC15 protein is an inhibitory receptor for SARS-CoV-2 spike-mediated entry

SARS-CoV-2 Delta spike increases viral virulence and inflammatory cytokine production

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Targeted measures to prevent the spread of Omicron variant take effect from 30 November 2021

Cytomegalovirus herpesvirus can accelerate the decline of the immune system, study finds

Money recovered in corruption case used for providing life-saving support to vulnerable people in Chad

Childhood cancer diagnosis not delayed in Canada during the pandemic, study says

Novel influenza vaccine candidate shows promise

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

An update of what is currently known about Omicron

The Rockefeller Foundation and WHO review strategic directions of collaboration to promote global health

European study endorses dashboards for public reporting during the COVID-19 pandemic

AVAT, Africa CDC and COVAX release statement regarding donations of COVID-19 vaccines to Africa

Simple change can maximize a single cell's production of extracellular vesicles

SARS-CoV-2 can directly invade human kidney cells, research shows

CDC strengthens recommendation on COVID-19 booster doses

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News